Chinese Journal of Antituberculosis ›› 2015, Vol. 37 ›› Issue (1): 56-65.doi: 10.3969/j.issn.1000-6621.2015.01.012
Previous Articles Next Articles
RAN Bing, CAI Lin
Received:
2014-05-30
Online:
2015-01-10
Published:
2015-02-08
Contact:
CAI Lin
E-mail:guke3559@aliyun.com
RAN Bing, CAI Lin. Diagnostic accuracy of gene chip in identifying rifampicin resistance Mycobacterium tuberculosis: a Meta-analysis[J]. Chinese Journal of Antituberculosis, 2015, 37(1): 56-65. doi: 10.3969/j.issn.1000-6621.2015.01.012
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2015.01.012
[1]World Health Organization.Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva:World Health Organization, 2010 (WHO/HTM/TB/2010).[2]Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med, 2012, 366(23): 2161-2170.[3]Wei J, Guo N, Liang J, et al.DNA microarray gene expression profile of Mycobacterium tuberculosis when exposed to osthole. Pol J Microbiol, 2013,62(1):23-30.[4]Koser CU, Bryant JM, Becq J, et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. New Engl J Med,2013,369(3):290-292.[5]Almeida Da Sliva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.J Antimicrob Chemother,2011, 66(7):1417-1430.[6]Mokrousov I, Jiao WW, Sun GZ, et al. Evalution of the rpoB macroarray assay to detect rifampin resistance in Mycobacterium tuberculosis in Beijing China. Eur J Clin Microbiol Infect Dis,2006, 25(11):703-710.[7]Yue J, Shi W, Xie J, et al. Detection of rifampin-resistant Mycobacterium tuberculosis strains by using a specialized oligonucleotide microarray. Diagn Microbiol Infect Dis,2004,48(1):47-54.[8]Whiting P,Rutjes AW,Reitsma JB,et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 2003,3: 25.[9]张晓光,张小利,帕丽达·帕尔哈提,等.超声造影对乳腺肿块良恶性鉴别诊断价值的系统评价.中国循证医学杂志,2014,14(1):79-84.[10]张天嵩,钟文昭.Meta-DiSc软件在诊断试验Meta分析中的应用.循证医学,2008,8(2):97-100.[11]Kim SY, Park YJ, Song E, et al. Evaluation of the CombiChip Mycobacterium Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. Diag Microbiol Infect Dis, 2006, 54(3):203-210.[12]Zhang Z, Li L, Luo F, et al. Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBioTM DNA microarray: a prospective validation study. BMC Infect Dis,2012,14(12):303-311.[13]Park H, Song EJ, Song ES, et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates.J Clin Microbiol, 2006,44(5):1619-1624.[14]Jiao WW, Mokrousov I, Sun GZ, et al. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J(Engl),2007,120(9):814-819.[15]张俊仙, 吴雪琼,阳幼荣,等.应用基因芯片方法检测结核分枝杆菌利福平和异烟肼的耐药性.中国防痨杂志,2011,33(10):680-685.[16]吴雪琼,张琼,张俊仙,等.应用基因芯片分析结核分枝杆菌常见耐药基因型的研究.中国防痨杂志,2006,28(1):4-10.[17]姚春艳, 张立群, 府伟灵. 应用基因芯片技术检测结核分枝杆菌耐药基因. 中华医院感染学杂志,2010,20(11):1501-1504.[18]李卫彬,李新旭,张彤群,等. 基因芯片检测技术检测结核分枝杆菌异烟肼和利福平耐药的实际应用效果评价,中华临床医师杂志(电子版),2012,6(16):4666-4670.[19]张俊仙,吴雪琼,邢婉丽,等. 应用基因芯片技术检测耐利福平结核分枝杆菌基因型. 中国现代医学杂志,2007,17(13): 1572-1577.[20]潘建华,彭雪峰,邓为之,等.DNA芯片技术检测结核分枝杆菌耐药基因.临床肺科杂志,2010,15(6):825-827.[21]Pang Y, Xia H, Zhang Z, et al. Multicenter evaluation of gene chip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol,2013,51(6):1707-1713.[22]Sun AH, Fan XL, Li LW, et al.Rapid detection of ropB gene mutation in Rif- resistance tuberculosis isolates by oligonucleotide microarray. Biomed Environ sci,2009,22(3):253-258.[23]何敏,曾尔良,郑艳燕,等.利用基因芯片检测结核分支杆菌及其利福平耐药性的研究.中华流行病学杂志,2003,24(5):385-388.[24]Ao W, Aldous S, Woodruff E, et al. Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol,2012,50(7):2433-2440.[25]Caoili JC, Mayorova A, Sikes D, et al. Evalution of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis.J Clin Microbiol,2006,44(7):2378-2381.[26]李芳芳,唐曙明,李爱敏,等.膜芯片技术对结核分枝杆菌耐药性检测的研究.国际检验医学杂志,2013,34(21):2792-2794.[27]梁莉,乐军,肖和平,等.利用基因芯片技术检测耐利福平分离株rpoB基因突变的研究.中华医院感染学杂志,2005,15(8):841-844.[28]Zhang SL, Shen JG, Xu PH,et al. A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array.J Appl Microbiol,2007,103(4):1262-1271.[29]赵冰,时金艳,逄宇,等. 基因芯片结核分枝杆菌耐多药检测在地市级实验室的应用性评估.中国防痨杂志,2013,35(9): 718-722.[30]李锋,李凫坚,陈园园,等. 应用基因芯片快速检测结核分枝杆菌利福平耐药基因的研究. 中国防痨杂志, 2011,33(3):188-189.[31]Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in a Meta-analyses. BMJ,2003,327(7414):557-560.[32]Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions Version5.1.0.[2011-03-01]. http://www.cochrane.org/handbook.org.[33]Jnawali HN, Hwang SC, Park YK, et al. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagnb Microbiol Infect Dis,2013,76(2):187-196.[34]陈效友,黄海荣,马屿,等.荧光定量PCR技术快速检测rpoB基因突变及其临床应用.中国防痨杂志,2007,29(5):386-390.[35]Mikhailovich V, Lapa S, Gryadunov D, et al. Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucle-otide microchips.J Clin Microbiol,2001,39(7):2531-2540.[36]谢士达,刘成永,张凤池,等.基因芯片技术快速检测结核分枝杆菌异烟肼、利福平耐药性.临床肺科杂志,2008,1(2):147-149.[37]王峰,朱玉梅,桂静,等.PCR测序和基因芯片快速鉴定分枝杆菌菌种的应用研究.中国防痨杂志,2011,33(11):713-717.[38]Steingart KR, Schiller I, Horne DJ, et al. Xpert@ MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database syst Rev,2014, 1: CD009593.[39]Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance:a multicentre implementation study. Lancet, 2011,377(9776):1495-1505. |
[1] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[2] | Song Feier, Mao Yanjun, Xia Qiuyue, Zhou Yang, Lin Huan. The prevalence and influencing factors of post-tuberculosis lung disease: A Meta-analysis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 322-330. |
[3] | Shi Yilin, Gu Yan. Meta-analysis of the efficacy, adverse reactions, and fatality rate of glucocorticoid combined with anti-tuberculosis drugs in the treatment of tuberculous serositis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 77-86. |
[4] | Wu Jinfeng, Yang Zhen, Zhang Fuzhen, Yao Cong. Meta-analysis of the diagnostic value of oral swab for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 815-822. |
[5] | Zhang Hongtai, Ren Yixuan, Hu peilei, Wang Nenhan, Li Jie, Tian Lili, Zhao Yanfeng, Chen Shuangshuang, Li Chuanyou. Comparison of microbiota diversity in the sputum of pulmonary tuberculosis patients with rifampicin resistance or sensitivity [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 625-633. |
[6] | Gulina Badeerhan, Liu Nianqiang, Yipaer Aihaiti, Wang Le, Wang Senlu, Zulikatiayi Abudula, Wang Mingzhe, Zhang Jing, Wang Xinqi, Bi Hongbo. The effect of GeneXpert MTB/RIF detection technology in tuberculosis prevention and control program in Xinjiang [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 173-177. |
[7] | Ruan Yunzhou, Su Wei, Zhang Hui, Zhao Yanlin. Historical evolution and prospect of rifampicin-resistant tuberculosis prevention and control in China [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1166-1170. |
[8] | Li Jing, Jiang Qi, Jiang Yuan, Shen Xin. Evaluation of performance of PCR fluorescent probe method for detecting Mycobacterium tuberculosis complex and rifampicin resistance [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1250-1258. |
[9] | Liu Mei, Wu Xia, Gu Xu, Li Nana, Zhang Wanmin, Zhang Xiaoke, Lan Yuanbo. Evaluation of the performance of InnowaveDX MTB/RIF in detecting Mycobacterium tuberculosis complex and rifampicin resistance [J]. Chinese Journal of Antituberculosis, 2024, 46(1): 70-74. |
[10] | Zheng Rui, Zhao Mingrui, Yang Yuanzheng. Meta-analysis of effectiveness and safety of the cycloserine-containing treatment for multidrug-resistant pulmonary tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 658-668. |
[11] | Lyu Tong, Yang Yunbin, Pan Ying, Cheng Yuyu, Li Zichao, Xu Lin. Analysis of economic burden and influencing factors of rifampin-resistant pulmonary tuberculosis in Yunnan Province [J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1031-1037. |
[12] | Chen Daiquan, Lin Shufang, Dai Zhisong, Zhou Yinfa, Chen Kun. Construction and validation of a nomogram for predicting unfavorable treatment outcomes among patients with rifampicin-sensitive tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(10): 957-966. |
[13] | Cheng Xiao, Chen Zhe, Jiao Xuefeng, Yang Nan, Diao Sha, Ni Xiaofeng, Liu Zheng, He Siyi, Zeng Linan, Wan Chaomin, Kang Deying, Wu Bin, Ying Binwu, Zhang Hui, Zhao Rongsheng, Zhang Lingli. Efficacy and safety of recombinant Mycobacterium tuberculosis fusion proteins (EC) for the diagnosis of Mycobacterium tuberculosis infection: A system review [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 917-926. |
[14] | YU Chun-hong, LIU Xing, SHEN Ling-jun, LI Hai-wen, LI Xie, WU Rong-shuang, LI Xian-rui, FAN Hao. Meta analysis of efficacy and safety of the treatment containing bedaquiline for multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 660-668. |
[15] | WANG Wei, YE Yi-nong, LIN Dong-zi, ZHONG Qian-hong, HUANG Fei, DU Fang-fang, CHENG Shi-ming, ZHOU Jie, ZHANG Xi-lin, ZHONG Qiu. Analysis of epidemiological characteristics of rifampicin resistance tuberculosis in Foshan City, Guangdong Province, 2011-2020 [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 187-192. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||